n(4)-hexadecyl-1-arabinofuranosylcytosine has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horber, DH; Schott, H; Schwendener, RA | 1 |
1 other study(ies) available for n(4)-hexadecyl-1-arabinofuranosylcytosine and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cytarabine; Deamination; DNA; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Liposomes; Mice; Microsomes, Liver; Tumor Cells, Cultured | 1995 |